10.12.2012 Views

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Document<br />

Page 193<br />

The enzyme 11β-HSD interconverts the active glucocorticoid cortisol and cortisone, an inactive<br />

metabolite (Figure 1a). By the oxidation of cortisol to cortisone, 11β-HSD prevents glucocorticoids<br />

from deleterious actions in certain cell types. For example, excess glucocorticoids in Leydig cells inhibit<br />

testosterone synthesis [3,11]. Expression of 11β-HSD in Leydig cells prevents this effect of<br />

glucocorticoids. In this way, 11β-HSD is important in androgen action. The enzyme 11β-HSD is also<br />

important in aldosterone action in the distal tubule of the kidney. Glucocorticoids have high affinity for<br />

the mineralocorticoid receptor [12] and can stimulate the mineralocorticoid response—uptake of sodium<br />

from urine—one effect of which is to increase blood pressure. Local expression of 11β-HSD in the<br />

distal tubule prevents this effect of glucocorticoids. The steroid aldosterone, which is not metabolized <strong>by</strong><br />

11β-HSD, can bind to the mineralocorticoid receptor and regulate sodium and potassium balance. Thus,<br />

11β-HSD has an important role in regulating the biological actions of both glucocorticoids and<br />

mineralocorticoids.<br />

As would be expected, interference with 11β-HSD activity due to a mutation [13,14] or <strong>by</strong> an inhibitor<br />

such as licorice (Figure 2) [1–3,15] has a variety of physiological effects including high blood pressure<br />

due to mineralocorticoid actions of glucocorticoids in the kidney's distal tubule. Thus, studies to unravel<br />

genetic hypertension in children and the actions of aldosterone in the kidney yielded the general insight<br />

that, at specific times, altered expression of 11β-HSD in specific tissues is an important mechanism for<br />

regulating glucocorticoid, mineralocorticoid, and androgen action.<br />

A similar mechanism has been found for 17β-hydroxysteroid dehydrogenase (17β-HSD), the enzyme<br />

that regulates the concentrations of estradiol and testosterone in human [5,16,17] (Figure 1b). Genetics<br />

diseases associated with mutations in this enzyme lead to developmental abnormalities [18]. Enzymes<br />

that regulate the concentrations of retinoids [19] and prostaglandins [20] may also have a similar role<br />

[6].<br />

B. Multiple Divergent 11β-Hydroxysteroid and 17β-Hydroxysteroid Dehydrogenases<br />

The cloning and sequencing of 11β-HSD [21–25] and 17β-HSD [16–18,26] revealed two 11β-HSDs and<br />

four 17β-HSDs with very different sequences<br />

http://legacy.netlibrary.com/nlreader/nlReader.dll?bookid=12640&filename=Page_193.html [4/5/2004 5:05:01 PM]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!